Financial Performance - For the fiscal year 2022, the company's revenue reached approximately HKD 1,121.8 million, representing a significant increase of about 71.3% compared to the fiscal year 2021[10]. - The company's revenue for the fiscal year 2022 reached approximately HKD 1,121.8 million, representing an increase of about 71.3% compared to HKD 654.7 million in the fiscal year 2021[23]. - Revenue from primary healthcare services increased by approximately HKD 485.2 million or 103.5% to about HKD 954.1 million, driven by rising demand for preventive, testing, vaccination, and outreach services[24]. - Revenue from specialist medical services decreased by approximately HKD 21.8 million or 17.2% to about HKD 104.4 million, primarily due to a reduction in patient visits[24]. - Revenue from dental services increased by approximately HKD 3.7 million or 6.2% to about HKD 63.2 million, attributed to an increase in average spending per visit[24]. - The company's gross profit increased by approximately HKD 283.0 million or 75.1% to about HKD 659.7 million in the fiscal year 2022, driven by revenue growth[28]. - The gross profit margin rose from approximately 57.5% in fiscal year 2021 to about 58.8% in fiscal year 2022, attributed to a higher proportion of revenue from general medical services[28]. - The profit attributable to the company's owners for fiscal year 2022 was approximately HKD 375.3 million, a significant increase of about 159.8% from HKD 144.5 million in fiscal year 2021[42]. - Other income and gains increased from approximately HKD 26.9 million to about HKD 32.3 million, mainly due to an increase in fair value changes of financial assets[34]. - Administrative expenses rose by approximately HKD 11.2 million or 4.9% to about HKD 241.8 million, primarily due to increases in property, plant, and equipment impairment[35]. Strategic Initiatives - The company plans to establish a new large health mall in Tsim Sha Tsui, covering over 38,000 square feet, to expand its service offerings[14]. - The establishment of the large health mall is expected to create new revenue streams and enhance the existing medical service network[14]. - The company plans to invest significant resources in the rehabilitation service sector to meet the growing demand in the Hong Kong market in the next fiscal year[15]. - A strategic partnership has been established with the Chinese University of Hong Kong to enhance the pilot program for injured employee rehabilitation, aiming to create greater synergy[15]. - The company is focused on digital transformation, planning to launch a new integrated clinic operation platform in the next fiscal year to improve stakeholder engagement and operational efficiency[19]. - The group is expanding its online business to optimize its e-commerce platform and provide a wider range of healthcare products and services[56]. - The group is committed to investing significant resources to upgrade and optimize its specialist medical centers' equipment and facilities in the next fiscal year[57]. - The group is exploring potential collaboration opportunities to enhance the service offerings of the health mall[81]. - The group is actively seeking partnerships to address the aging population issue by providing home care services for the elderly and those in need[87]. Community Engagement and Corporate Social Responsibility - The company continues to support the Hong Kong government's anti-epidemic measures while diversifying its primary care services[11]. - The company is committed to corporate social responsibility and actively supports community health initiatives[11]. - The group is actively involved in vaccination subsidy programs, providing flu and pneumonia vaccines, and promoting various vaccination activities[50]. - The group has been approved for a pilot program by the Labour Department to provide timely and coordinated private outpatient rehabilitation services for construction workers who have not returned to work after six weeks of injury[84]. - The group has pledged to continue participating in community health-related programs to offer convenient and comprehensive services[87]. Operational Efficiency and Technology - The company has a stable cash flow that allows for accelerated service expansion to meet various health service demands[14]. - The company emphasizes the use of advanced medical equipment, professional talent, cutting-edge technology, and big data analysis in its new health mall[14]. - The group is focusing on enhancing its information technology infrastructure and digital platforms to improve stakeholder engagement and client acquisition[58]. - The group introduced a new generation integrated clinic operation platform to manage B2C, B2B, and B2G interactions[61]. - The introduction of an "eHealth station" and an automated ticketing system is expected to improve customer experience by streamlining health check processes and reducing waiting times[80]. - The group is committed to continuous investment in digitalization, enhancing IT infrastructure, digital platforms, and upgrading medical equipment to improve operational efficiency and service experience[79]. Governance and Leadership - The company has adopted the corporate governance code as per the listing rules and has complied with all applicable provisions for the fiscal year 2022, except for a deviation from provision C.2.1[144]. - The Chairman and CEO roles are held by the same individual, Mr. Chan, which the board believes enhances internal leadership consistency and effective strategic planning[145]. - The board consists of seven directors, including four executive directors and three independent non-executive directors[153]. - The company has established procedures for directors to seek independent advice at the company's expense when necessary[150]. - The company has implemented appropriate liability insurance for directors and senior management to cover responsibilities arising from business operations[151]. - The board is committed to maintaining a high standard of corporate governance and compliance with relevant regulations[172]. - The board's diversity policy aims to achieve sustainable and balanced development by considering various factors including gender, age, cultural background, and ethnicity[191]. - The company emphasizes the importance of diversity in its board composition as a key element for achieving strategic goals[191]. Future Outlook - The group anticipates a cautious business growth outlook for the next fiscal year due to the ongoing impact of the pandemic, with expected demand for COVID-19 related services decreasing compared to fiscal year 2022[76]. - The company has outlined a future outlook with a projected revenue growth of 12% for the next fiscal year[138]. - The management team emphasized a commitment to improving operational efficiency, aiming for a 5% reduction in costs by the end of 2023[138]. - The company plans to expand its market presence in Southeast Asia, targeting a 20% increase in market share by 2025[138]. - A strategic acquisition of a local dental service provider is anticipated to enhance service offerings and operational efficiency[138].
盈健医疗(01419) - 2022 - 年度财报